Analysis of Biomarkers From Patients With Chorioretinal Diseases
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age20-80
SponsorKyungpook National University Hospital
About this trial
This study was conducted to investigate the levels of ocular biomarkers from the patients with chorioretinal diseases including diabetic retinopathy, retinal vascular diseases, age-related macular degeneration (dry and wet), and retinal degeneration.
Eligibility criteria
Qualifiers
age over 20 years
patients requiring ophthalmologic treatments for different degrees of decreasing of visual acuity.
patients with chorioretinal diseases including diabetic retinopathy, retinal vascular diseases, age-related macular degeneration (dry and wet), and retinal degeneration.
control patients asking cataract surgery or vitrectomy for posterior segment nonproliferative disorders.
Disqualifiers
under the age of 20 years
patients that received any anti-vascular endothelial growth factor agent for proliferative disease before taking sample of aqueous humor
patients that did not signed the informed consent of the trial
patients with intraocular inflammations or infections that requiring any pharmaceutical agent
Trial design
Treatments tested in this trial
- Chorioretinal diseases
Treatment groups
100 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov